Pharmaceutical - Women's Health, Ligand Pharmaceuticals

Filter

Popular Filters

US FDA backs Pfizer’s hot flashes drug Duavee

US FDA backs Pfizer’s hot flashes drug Duavee

04-10-2013

Pfizer and partner Ligand Pharmaceuticals say that the US Food and Drug Administration has approved Duavee,…

bazedoxifeneDuaveeLigand PharmaceuticalsNorth AmericaPfizerPharmaceuticalRegulationWomen's Health

Ligand enters global license deal for women's health product

23-07-2013

Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

FDA accepts NDA filings from Pfizer/Ligand and Actelion; Bayer submits Alpharadin

16-12-2012

The US Food and Drug Administration accepted for review a New Drug Application from pharma behemoth Pfizer…

AlgetaAlpharadinBayerbazedoxifeneBiotechnologyConjugated EstrogensLigand PharmaceuticalsNorth AmericaOncologyOpsumitPfizerPharmaceuticalRegulationRespiratory and PulmonaryWomen's Health

COMPANY SPOTLIGHT

Menarini

Back to top